Atlas Trials

Pilot Study to Explore the Efficacy of DAPAglifozin as add-on to Closed-loop Control in Patients With Type 1 Diabetes

Clinical trial NCT02987738 · COMPLETED

Trial details

NCT number
NCT02987738
Sponsor
Kinderkrankenhaus auf der Bult
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type1diabetes
Start date
2017-02-09
Primary completion
2017-12-19
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.